This element equips candidates with the knowledge and skills to legally and responsibly prescribe and supply veterinary medicines to companion animals as a
Topic Synopsis
This element equips candidates with the knowledge and skills to legally and responsibly prescribe and supply veterinary medicines to companion animals as an SQP, strictly adhering to the VMD Code of Practice. It also instils the critical importance of pharmacovigilance through prompt and accurate adverse event reporting, safeguarding animal welfare, public health, and regulatory compliance.
Key Concepts & Core Principles
- Veterinary Medicines Regulations (VMR): Understand the legal categories of medicines (POM-V, POM-VPS, NFA-VPS, AVM-GSL) and the specific responsibilities of an SQP in supplying POM-VPS and NFA-VPS products for companion animals.
- Pharmacology basics: Know the principles of drug absorption, distribution, metabolism, and excretion (ADME), as well as common drug classes used in companion animals (e.g., anthelmintics, ectoparasiticides, NSAIDs, antibiotics) and their mechanisms of action.
- Responsible medicine use: Emphasise the importance of correct dosing, adherence to withdrawal periods (where applicable), recognition of adverse reactions, and strategies to combat antimicrobial resistance through prudent prescribing and client education.
- Companion animal anatomy and physiology: Be able to identify key body systems (e.g., digestive, respiratory, integumentary) and common conditions affecting them, such as flea allergy dermatitis, otitis externa, or gastrointestinal parasites, to make informed treatment recommendations.
- Client communication and record-keeping: Develop skills to gather accurate patient histories, explain treatment plans clearly, obtain informed consent, and maintain detailed records as required by law and professional standards.
Exam Tips & Revision Strategies
- When tackling case-study questions, systematically check the medicine's legal category against the SQP's permitted scope and the client's authority before deciding to supply.
- Familiarize yourself with the VMD's online reporting form fields so you can swiftly identify missing information in scenario-based adverse event reporting tasks.
- Always link your answers back to the principles of the Code of Practice (e.g., procurement, storage, supply, record-keeping) to demonstrate holistic understanding.
- For verbal or role-play assessments, practice clear explanations of risks and side effects to clients—this mirrors real-world SQP consultations and shows competence in client education.
Common Misconceptions & Mistakes to Avoid
- Confusing the supply classification of veterinary medicines, particularly assuming all products for companion animals fall under the same SQP access category (e.g., incorrectly supplying a POM-V product instead of referring to a veterinary surgeon).
- Failing to report a suspected adverse event because it appears mild or obvious, overlooking that all suspected events, including lack of efficacy, must be recorded and reported to the VMD.
- Neglecting to obtain or record consent from the animal owner when reporting an adverse event, or not providing adequate privacy information about how their data will be used.
- Misinterpreting 'under care' provisions, leading to supplying medicines without an appropriate clinical assessment or when a valid veterinary prescription is required.
Examiner Marking Points
- Award credit for correctly interpreting and applying the VMD Code of Practice to a given scenario, including appropriate categorization of medicines (POM-V, POM-VPS, NFA-VPS) and associated supply conditions.
- Award credit for demonstrating thorough client communication on safe medicine use, storage, withdrawal periods, and disposal, as mandated by the Code.
- Award credit for accurately identifying reportable adverse events and completing a VMD adverse event report form with all required critical details, including animal and owner data, medicine information, and nature of the event.
- Award credit for explaining the legal record-keeping obligations for medicine supply and adverse event reporting, including retention periods and data protection considerations.